Literature DB >> 23397252

Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?

Anthony O Ahmed1, Peter F Buckley, Mona Hanna.   

Abstract

Schizophrenia is characterized by neurostructural and neurofunctional aberrations that have now been demonstrated through neuroimaging research. The article reviews recent studies that have attempted to use neuroimaging to understand the relation between neurological abnormalities and aspects of the phenomenology of schizophrenia. Neuroimaging studies show that neurostructural and neurofunctional abnormalities are present in people with schizophrenia and their close relatives and may represent putative endophenotypes. Neuroimaging phenotypes predict the emergence of psychosis in individuals classified as high-risk. Neuroimaging studies have linked structural and functional abnormalities to symptoms; and progressive structural changes to clinical course and functional outcome. Neuroimaging has successfully indexed the neurotoxic and neuroprotective effects of schizophrenia treatments. Pictures can inform about aspects of the phenomenology of schizophrenia including etiology, onset, symptoms, clinical course, and treatment effects but this assertion is tempered by the scientific and practical limitations of neuroimaging.

Entities:  

Mesh:

Year:  2013        PMID: 23397252     DOI: 10.1007/s11920-012-0345-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  97 in total

1.  An fMRI study of differential neural response to affective pictures in schizophrenia.

Authors:  Hidehiko Takahashi; Michihiko Koeda; Kenji Oda; Tetsuya Matsuda; Eisuke Matsushima; Masato Matsuura; Kunihiko Asai; Yoshiro Okubo
Journal:  Neuroimage       Date:  2004-07       Impact factor: 6.556

2.  Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders.

Authors:  Sanjiv Kumra; Paul Robinson; Rabindra Tambyraja; Daniel Jensen; Caroline Schimunek; Alaa Houri; Tiffany Reis; Kelvin Lim
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-14       Impact factor: 8.829

Review 3.  Episodic memory-related activation in schizophrenia: meta-analysis.

Authors:  Amélie M Achim; Martin Lepage
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

4.  Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia.

Authors:  Nicoletta M J van Veelen; Matthijs Vink; Nick F Ramsey; Mariët van Buuren; Janna Marie Hoogendam; René S Kahn
Journal:  Schizophr Res       Date:  2011-04-15       Impact factor: 4.939

5.  Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up.

Authors:  Peter Milev; Beng-Choon Ho; Stephan Arndt; Peggy Nopoulos; Nancy C Andreasen
Journal:  Biol Psychiatry       Date:  2003-09-15       Impact factor: 13.382

6.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

Authors:  D H Mathalon; E V Sullivan; K O Lim; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  2001-02

7.  Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.

Authors:  Tsutomu Takahashi; Stephen J Wood; Alison R Yung; Bridget Soulsby; Patrick D McGorry; Michio Suzuki; Yasuhiro Kawasaki; Lisa J Phillips; Dennis Velakoulis; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2009-04

8.  Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions.

Authors:  André Quincozes-Santos; Larissa Daniele Bobermin; Rafaela Pestana Leques Tonial; Victorio Bambini-Junior; Rudimar Riesgo; Carmem Gottfried
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-30       Impact factor: 5.270

Review 9.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

Review 10.  Prefrontal activation deficits during episodic memory in schizophrenia.

Authors:  John D Ragland; Angela R Laird; Charan Ranganath; Robert S Blumenfeld; Sabina M Gonzales; David C Glahn
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

View more
  5 in total

1.  Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management.

Authors:  Jonathan R Stevens; Jefferson B Prince; Laura M Prager; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-13

2.  Application of Mass Multivariate Analysis on Neuroimaging Data Sets for Precision Diagnostics of Depression.

Authors:  Rositsa Paunova; Sevdalina Kandilarova; Anna Todeva-Radneva; Adeliya Latypova; Ferath Kherif; Drozdstoy Stoyanov
Journal:  Diagnostics (Basel)       Date:  2022-02-12

Review 3.  Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

Authors:  Anthony O Ahmed; Ishrat A Bhat
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

Review 4.  A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.

Authors:  Anthony O Ahmed; Samantha Kramer; Naama Hofman; John Flynn; Marie Hansen; Victoria Martin; Anilkumar Pillai; Peter F Buckley
Journal:  Neuropsychobiology       Date:  2021-03-11       Impact factor: 2.328

5.  Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data.

Authors:  Elisabetta Caletti; Riccardo A Paoli; Alessio Fiorentini; Michela Cigliobianco; Elisa Zugno; Marta Serati; Giulia Orsenigo; Paolo Grillo; Stefano Zago; Alice Caldiroli; Cecilia Prunas; Francesca Giusti; Dario Consonni; A Carlo Altamura
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.